Sugi Predict

Sugi Predict / Compounds / SCHEMBL19933570

SCHEMBL19933570

SCHEMBL19933570

CC(C)(O)C(C)(C)OBc1ccc(-c2cnc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cc3)cn2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 2/20 0.42
▸ LIPG Q9Y5X9 9/20 0.40
▸ LPL P06858 8/20 0.40
▸ SNCA P37840 1/20 0.37
▸ FFAR1 O14842 1/20 0.36
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ CA12 O43570 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ CA5A P35218 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ CA5B Q9Y2D0 1/20 0.33
▸ F11 P03951 2/20 0.32
▸ AAK1 Q2M2I8 1/20 0.32
▸ F2 P00734 1/20 0.31
▸ PRSS1 P07477 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19933572 0.89 DGAT1 (0.50) DGAT1LIPGLPLSNCAFFAR1
SCHEMBL14854199 0.88 CA1 (0.43) DGAT1LIPGLPLSNCAFFAR1
SCHEMBL19933561 0.86 SNCA (0.36) DGAT1LIPGLPLSNCACA1
SCHEMBL21125908 0.86 LIPG (0.41) DGAT1LIPGLPLSNCAFFAR1
SCHEMBL23018776 0.85 DGAT1 (0.45) DGAT1LIPGLPLSNCAFFAR1
SCHEMBL23018805 0.79 LIPG (0.59) DGAT1LIPGLPLSNCACA1
SCHEMBL23625698 0.77 LIPG (0.43) LIPGLPLFFAR1CA1CA2
SCHEMBL18807543 0.76 LIPG (0.38) LIPGLPLSNCACA1CA2
SCHEMBL16533081 0.76 DGAT1 (0.38) DGAT1FFAR1AAK1
SCHEMBL12103836 0.76 LPL (0.41) DGAT1LIPGLPLSNCAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices MERCK PATENT GMBH 2021-01-12 — — US disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 — — US disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG DGAT1 2586/4885LIPG 4374/4885LPL 4558/4885
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices PARN, PUF60, PARG DGAT1 2586/4885LIPG 4374/4885LPL 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.